Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0F4SY
|
||||
Former ID |
DIB014244
|
||||
Drug Name |
Pridopidine
|
||||
Synonyms |
Huntexil; Pridopidine hydrochloride; ACR-16; ASP-2314; Dopamine modulator (Huntingtons disease), Carlsson Research; Dopamine modulator (Huntingtons disease), NeuroSearch; Dopamine modulator (schizophrenia), Astellas; Dopamine modulator (schizophrenia), Fujisawa; Dopamine modulator (neurological disorders), Merck & Co
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Huntington's disease [ICD9: 294.1, 333.4; ICD10:F02.2, G10] | Phase 3 | [522303] | ||
Company |
Teva pharmaceutical
|
||||
Structure |
Download2D MOL |
||||
Formula |
C15H23NO2S
|
||||
Canonical SMILES |
S(=O)(=O)(c1cc(C2CCN(CC2)CCC)ccc1)C
|
||||
CAS Number |
CAS 346688-38-8
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | D(2) dopamine receptor | Target Info | Modulator | [531022] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.